Effect of single doses of SLV306, an inhibitor of both neutral endopeptidase and endothelin-converting enzyme, on pulmonary pressures in congestive heart failure. [electronic resource]
Producer: 20040810Description: 237-9 p. digitalISSN:- 0002-9149
- Aged
- Aspartic Acid Endopeptidases -- antagonists & inhibitors
- Benzazepines -- administration & dosage
- Blood Pressure -- drug effects
- Cardiac Output -- drug effects
- Endothelin-Converting Enzymes
- Female
- Heart Failure -- physiopathology
- Heart Rate -- drug effects
- Humans
- Male
- Metalloendopeptidases
- Middle Aged
- Neprilysin -- antagonists & inhibitors
- Pulmonary Artery -- physiology
- Pulmonary Wedge Pressure -- drug effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.